.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Johnson and Johnson
Healthtrust
Colorcon
Queensland Health
Julphar
McKinsey
Fish and Richardson
US Department of Justice
Deloitte

Generated: September 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074520

« Back to Dashboard
NDA 074520 describes OXYBUTYNIN CHLORIDE, which is a drug marketed by Mylan, Osmotica Pharm Us, Amneal Pharms, Silarx, Unique Pharm Labs, Usl Pharma, Zydus Pharms Usa Inc, Pharm Assoc, Accord Hlthcare, Mikart, Mylan Pharms Inc, Impax Pharms, Teva Pharms Usa, Wockhardt, Vintage Pharms, Watson Labs, Quantum Pharmics, and Apotex Inc, and is included in twenty NDAs. It is available from forty-six suppliers. Additional details are available on the OXYBUTYNIN CHLORIDE profile page.

The generic ingredient in OXYBUTYNIN CHLORIDE is oxybutynin chloride. There are sixteen drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the oxybutynin chloride profile page.

Summary for NDA: 074520

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Genitourinary Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 074520

Suppliers and Packaging for NDA: 074520

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OXYBUTYNIN CHLORIDE
oxybutynin chloride
SYRUP;ORAL 074520 ANDA Silarx Pharmaceuticals, Inc 54838-510 54838-510-80 473 mL in 1 BOTTLE, PLASTIC (54838-510-80)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SYRUP;ORALStrength5MG/5ML
Approval Date:Mar 29, 1996TE:AARLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Mallinckrodt
Fish and Richardson
Boehringer Ingelheim
Accenture
Chubb
UBS
Cipla
AstraZeneca
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot